Examine This Report on pentobarbital drug
Examine This Report on pentobarbital drug
Blog Article
pentobarbital will decrease the level or effect of midostaurin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Strong CYP3A4 inducers could decrease midostaurin concentrations resulting in lessened efficacy.
pentobarbital will lessen the extent or effect of dapsone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.
pentobarbital improves toxicity of ifosfamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. CYP3A4 inducers may possibly enhance the metabolism of ifosfamide to its Lively alkylating metabolites.
pentobarbital will lessen the extent or effect of phenytoin by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Keep an eye on.
pentobarbital will lower the level or effect of fosphenytoin by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Monitor.
Keep an eye on Closely (one)pentobarbital will reduce the extent or influence of mifepristone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. CYP3A4 inducers haven't been examined, coadministration not recommended by manufacturer
pentobarbital will reduce the extent or outcome of flurbiprofen by impacting hepatic enzyme CYP2C9/10 metabolism. Insignificant/Importance Unknown.
pentobarbital will lessen the extent or result of etravirine by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Keep an eye on.
pentobarbital will lessen the level or effect of eltrombopag by impacting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Monitor.
This drug could interfere with the absorption of orally administered griseofulvin, decreasing its blood amounts; effects of blood level reduction unknown; preferable to avoid concomitant administration here of those drugs
Check Closely (1)pentobarbital will reduce the extent or result of gefitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or influence of ambrisentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.
pentobarbital will decrease the level or result of rolapitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Extensive-term coadministration of solid CYP3A4 inducers with rolapitant could considerably lower rolapitant efficacy.
Contraindicated (1)pentobarbital decreases amounts of vandetanib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay away from coadministration with potent CYP3A4 inducers; these drugs reduce exposure to vandetanib by around 40%.